Specialized Disclosure Report (sd)
May 31 2018 - 4:33PM
Edgar (US Regulatory)
United States
Securities and Exchange Commission
Washington, D.C. 20549
Form SD
Specialized Disclosure Report
INTEGRA
LIFESCIENCES HOLDINGS CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
0-26224
|
|
51-0317849
|
(State or other jurisdiction
of incorporation or organization)
|
|
Commission
File Number
|
|
(I.R.S. Employer
Identification No.)
|
311 ENTERPRISE DRIVE
PLAINSBORO, NEW JERSEY 08536
(Address of principal executive offices)
|
|
|
Glenn G. Coleman
Corporate Vice President and Chief Financial Officer
|
|
(609)
275-0500
|
(Name and telephone number, including area code, of the person to contact in connection with this report)
|
The rule pursuant to which this form is being filed, and the period to which the information in this form applies:
☒
|
Rule
13p-1
under the Securities Exchange Act (17 CFR
240.13p-1)
for the reporting period from January 1 to December 31, 2017
|
Section 1 Conflict Minerals Disclosure
Item 1.01 and 1.02 Conflict Minerals Disclosure and Exhibit
Integra LifeSciences Holdings Corporation (Integra, the Company, we, us or our) is unable, at this
time, to determine whether any of the tin, tantalum, tungsten or gold (the Conflict Minerals) used in its products may have originated in the Democratic Republic of the Congo or adjoining countries. Some of our suppliers have identified
that products they provide to us may include recycled Conflict Minerals.
A Conflict Minerals Report is provided as an Exhibit to this Report under
Section 2.01 below, and is available at the following internet website
https://www.integralife.com/ConflictMineralsPolicy.
The Conflict
Minerals Report is not required to be audited.
Section 2 Exhibits
Item 2.01 Exhibits
Exhibit 1.01
Conflict Minerals Report
A Conflict Minerals Report is attached.
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
|
|
|
|
|
|
|
|
|
INTEGRA LIFESCIENCES HOLDINGS CORPORATION
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ Glenn G. Coleman
|
|
|
|
|
|
May 31, 2018
|
|
|
Glenn G. Coleman
Chief Financial Officer and
Corporate Vice President, International
|
|
|
|
|
|
|
2
Integra LifeSciences (NASDAQ:IART)
Historical Stock Chart
From Mar 2024 to Apr 2024
Integra LifeSciences (NASDAQ:IART)
Historical Stock Chart
From Apr 2023 to Apr 2024